Inventor · disambiguated record
Drew Weissman
Also filed as: WEISSMAN DREW
28 granted patents·38 pending applications·1,551 citations·filing 2006–2025
97Inventor score
Files withUNIV PENNSYLVANIA53KARIKO KATALIN3BOSTON MEDICAL CT CORP2TRIAD NAT SECURITY LLC2WEISSMAN DREW2
Top patents by PatentIndex Score
66 records- 0198US10232055B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted Mar 19, 2019·96 cites·15 claims
- 0298US9012219B2RNA preparations comprising purified modified RNA for reprogramming cellsKARIKO KATALIN·Filed 2010·Granted Apr 21, 2015·116 cites·24 claims
- 0398US8835108B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2013·Granted Sep 16, 2014·207 cites·22 claims
- 0498US8748089B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2013·Granted Jun 10, 2014·227 cites·22 claims
- 0597US9750824B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2014·Granted Sep 5, 2017·59 cites·24 claims
- 0697US8691966B2RNA containing modified nucleosides and methods of use thereofKARIKO KATALIN·Filed 2012·Granted Apr 8, 2014·230 cites·21 claims
- 0797US8278036B2RNA containing modified nucleosides and methods of use thereofKARIKO KATALIN·Filed 2006·Granted Oct 2, 2012·564 cites·21 claims
- 0896US11060107B2Purification and purity assessment of RNA molecules synthesized with modified nucleosidesUNIV PENNSYLVANIA·Filed 2017·Granted Jul 13, 2021·13 cites·7 claims
- 0996US9371511B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2015·Granted Jun 21, 2016·9 cites·16 claims
- 1094US11801314B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2022·Granted Oct 31, 2023·1 cites·27 claims
- 1194US9163213B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2015·Granted Oct 20, 2015·10 cites·21 claims
- 1292US11028370B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2018·Granted Jun 8, 2021·4 cites·20 claims
- 1392US10006007B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2016·Granted Jun 26, 2018·9 cites·19 claims
- 1490US2024226335A9RNA Containing Modified Nucleosides and Methods of Use ThereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1588US11389547B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2019·Granted Jul 19, 2022·1 cites·19 claims
- 1687US11241490B2Nucleoside-modified RNA for inducing an immune response against zika virusUNIV PENNSYLVANIA·Filed 2018·Granted Feb 8, 2022·4 cites·16 claims
- 1787US2025019719A1Purification and Purity Assessment of RNA Molecules Synthesized with Modified NucleosidesUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 1885US11739300B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2020·Granted Aug 29, 2023·1 cites·14 claims
- 1984US2025064914A1Nucleoside-modified RNA for Inducing an Adaptive Immune ResponseUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 2081US12226471B2Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virusUNIV PENNSYLVANIA·Filed 2023·Granted Feb 18, 2025·0 cites·19 claims
- 2179US12364750B1Conserved region T cell vaccines for coronavirus and methods of useTRIAD NAT SECURITY LLC·Filed 2024·Granted Jul 22, 2025·0 cites·20 claims
- 2277US12138305B2Nucleoside-modified RNA for inducing an adaptive immune responseUNIV PENNSYLVANIA·Filed 2022·Granted Nov 12, 2024·0 cites·13 claims
- 2377US12054734B2Purification and purity assessment of RNA molecules synthesized with modified nucleosidesUNIV PENNSYLVANIA·Filed 2021·Granted Aug 6, 2024·0 cites·7 claims
- 2476US2025041436A1Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem CellsUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 2576US2024024463A1Modified mrna vaccines encoding herpes simplex virus glycoproteins and uses thereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2675US12161709B2Compositions for inducing an immune response against zika virusUNIV PENNSYLVANIA·Filed 2021·Granted Dec 10, 2024·0 cites·23 claims
- 2774US2024131181A1Therapeutic Targeting of Lipid NanoparticlesUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2871US12371666B2Nucleoside modified mRNA and uses thereofBOSTON MEDICAL CT CORP·Filed 2022·Granted Jul 29, 2025·0 cites·22 claims
- 2971US11793872B2Modified MRNA vaccines encoding herpes simplex virus glycoproteins and uses thereofUNIV PENNSYLVANIA·Filed 2021·Granted Oct 24, 2023·0 cites·25 claims
- 3071US2022040285A1Nucleoside-Modified RNA For Inducing an Adaptive Immune ResponseUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 3170US2025281593A1Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virusUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 3270US2025367131A1Ionizable lipids and methods of manufacture and use thereofUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 3369US12023376B1Conserved region T cell vaccines for coronavirus and methods of useTRIAD NAT SECURITY LLC·Filed 2021·Granted Jul 2, 2024·0 cites·15 claims
- 3469US2024018486A1Rna preparations comprising purified modified rna for reprogramming cellsUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 3568US11660332B2Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virusUNIV PENNSYLVANIA·Filed 2018·Granted May 30, 2023·0 cites·8 claims
- 3668US11141478B2Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Oct 12, 2021·0 cites·16 claims
- 3768US2024216523A1Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem CellsUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 3866US12458604B2Methods of lipid nanoparticle manufacture and compositions derived therefromGEORGE MASON RES FOUNDATION INC·Filed 2021·Granted Nov 4, 2025·0 cites·45 claims
- 3966US2025313806A1Nucleoside modified mrna and uses thereofBOSTON MEDICAL CT CORP·Filed 2025·Application pending·0 cites
- 4065US2016032316A1Purification and Purity Assessment of RNA Molecules Synthesized with Modified NucleosidesUNIV PENNSYLVANIA·Filed 2014·Application pending·0 cites
- 4164US2020093936A1Therapeutic Targeting of Lipid NanoparticlesUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 4264US2024343764A1Compositions for and methods of treating and/or preventing malariaUNIV GEORGE WASHINGTON·Filed 2024·Application pending·0 cites
- 4363US2024016922A1Rna vaccines encoding herpes simplex virus glycoproteins and uses thereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 4462US2025018021A1Norovirus vaccine and methods of useUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4561US2025114439A1mRNA VACCINES AGAINST TICK SALIVARY PROTEINS, AND METHODS OF USING SAMEUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4661US2018303925A1Nucleoside-Modified RNA For Inducing an Adaptive Immune ResponseUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 4760US2024226310A1Lipid Nanoparticle Therapeutics that Evade the Immune ResponseUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4860US2024374708A1Universal Influenza Vaccine and Methods of UseUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4960US2025120997A1Intraspinal delivery of therapeutic agentsUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 5060US2025340598A1Compositions comprising v2 opt hiv envelopesUNIV DUKE·Filed 2022·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Drew Weissman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →